Neurology Research International / 2020 / Article / Tab 1 / Research Article
Minimizing the Diagnostic Delay in Amyotrophic Lateral Sclerosis: The Role of Nonneurologist Practitioners Table 1 Diagnostic delay and intermediate delays of amyotrophic lateral sclerosis in the medical literature.
Reference Country Number of patients Diagnostic delay Intermediate delays Median (months) Average (months) Median (months) Average (months) Belsh and Schiffman [19 ] USA 64 — 12.3 — A-B (5.9) Brooks [11 ] USA 34 — 21.9 — C-E (8.7) Chiò [22 ] International 201 14 17–21 A-B (2); B–C (6); C-E (4) A-B (5.6); B–C (6); C-E (7) Househam and Swash [20 ] UK 57 — 16.2 A-B (3); B–C (5); C-E (2) A-B (5.2); B–C (7.2); C-E (3.8) Traynor et al. [23 ] Ireland 388 8 — — — Iwasaki et al. [24 ] Japan 117 — 11.7–12.7 — A-B (5.7); A-C (9.7) Chiò et al. [25 ] Italy 221 — 11.1 — — Zoccolella et al. [18 ] Italy 130 9.3 — — — Czaplinski et al. [26 ] USA 1041 13–14.2 — — — Torny et al. [10 ] France 77 7 11.7 A-B (2); B–C (3) A-B (4.7); B–C (6.9) Donaghy et al. [17 ] Northern Ireland 73 15.6 — A-B (3.1); B–C (5.2); C-E (1.9) — Chiò et al. [27 ] Italy 1260 — 10.4 — — Kraemer et al. [28 ] Germany 100 — 13.7 — — Mitchell et al. [16 ] England 640 11.4 — — — Turner et al. [29 ] Ireland 49 9–15 10–22 — — Logroscino et al. [6 ] Europe 1028 8.7 12.2 — — Cellura et al. [30 ] Italy 260 11 — A-B (3); B–C (3); C-E (5) — Williams et al. [31 ] USA 272 27 — — — Nzwalo et al. [32 ] Portugal 101 9.5 10.1 A-B (2); A-C (6) — Paganoni et al. [33 ] USA 304 11.5 — A-B (4); B-D0 (3) – D0 -E (1) — Scialo et al. [21 ] Italy 298 10 14.3 — — Knibb et al. [34 ] England 575 11.1 — — — Stevic et al. [35 ] Serbia 325 — 19.2 — — Yates and Rafiq [36 ] Europe 512 — 9.5 — — Calvo et al. [1 ] Italy 2648 14.2–15 — — — Galvin et al. [37 ] Ireland 155 11 15.1 A-B (3) A-B (5.2); B–C (6.1); C-E (3.8) Our study France 90 12 17 A-B (1.1); B–C (4); A-D0 (0); C-D0 (0); D0 -E (0.2) A-B (2.7); B–C (6.5); A-D0 (2.1); C-D0 (1.3); D0 -E (2.9) Average 408.1 12.1 14.2 A-B (2.6); B–C (4.4); C-E (3.2) A-B (5); B–C (6.5); C-E (5.8) Range 34–2648 7–27 9.5–21 A-B (1.1-4); B–C (3-6); C-E (1.9-5) A-B (2.7-5.9); B–C (6-7.2); C-E (3.8-8.7)
A-B = delay of complaint; A-C = delay for a neurologist consultation since the first symptom of the patient; A-D0 = delay of the first suspicion of ALS since the first symptom of the patient; B–C = delay for a neurologist consultation since the first complaint of the patient; B-D0 = delay of the first suspicion of ALS since the first complaint of the patient; C-D0 = delay to perform electroneuromyography; C-E = delay for the neurologist to make the diagnosis of ALS; D0 -E = delay for diagnosis confirmation.